Having demonstrated a mutual induction of both the β2AR agonist and RGM-A in inflammatory in-vitro and peritonitis experiments, we next sought to investigate a potential interaction between β-adrenergic signaling and RGM-A and the underlying mechanisms by which resolution programs are affected. Here, RGMA is linked to peritonitis.